WO1999061038A1 - Composition having therapeutic and/or nutritionally active substituent - Google Patents
Composition having therapeutic and/or nutritionally active substituent Download PDFInfo
- Publication number
- WO1999061038A1 WO1999061038A1 PCT/US1999/011886 US9911886W WO9961038A1 WO 1999061038 A1 WO1999061038 A1 WO 1999061038A1 US 9911886 W US9911886 W US 9911886W WO 9961038 A1 WO9961038 A1 WO 9961038A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- substituent
- beverage
- provides
- group
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 215
- 230000001225 therapeutic effect Effects 0.000 title description 5
- 230000007774 longterm Effects 0.000 claims abstract description 58
- 230000009286 beneficial effect Effects 0.000 claims abstract description 48
- 235000013361 beverage Nutrition 0.000 claims description 92
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 78
- 244000299461 Theobroma cacao Species 0.000 claims description 59
- 239000000284 extract Substances 0.000 claims description 44
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 claims description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 43
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 38
- 229960001948 caffeine Drugs 0.000 claims description 38
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 38
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 35
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 claims description 34
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 34
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 34
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims description 32
- LGEQQWMQCRIYKG-DOFZRALJSA-N anandamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO LGEQQWMQCRIYKG-DOFZRALJSA-N 0.000 claims description 30
- LGEQQWMQCRIYKG-UHFFFAOYSA-N arachidonic acid ethanolamide Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO LGEQQWMQCRIYKG-UHFFFAOYSA-N 0.000 claims description 30
- 241000218182 Eschscholzia Species 0.000 claims description 29
- 240000000143 Turnera diffusa Species 0.000 claims description 27
- 235000015203 fruit juice Nutrition 0.000 claims description 27
- 235000004952 turnera diffusa Nutrition 0.000 claims description 27
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 26
- 244000046146 Pueraria lobata Species 0.000 claims description 26
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 26
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 26
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims description 25
- 241000208672 Lobelia Species 0.000 claims description 24
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 24
- 235000019219 chocolate Nutrition 0.000 claims description 24
- 239000011777 magnesium Substances 0.000 claims description 24
- 229910052749 magnesium Inorganic materials 0.000 claims description 24
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Chemical compound OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 24
- 239000011701 zinc Substances 0.000 claims description 24
- 241000157855 Cinchona Species 0.000 claims description 23
- 235000008694 Humulus lupulus Nutrition 0.000 claims description 23
- 244000025221 Humulus lupulus Species 0.000 claims description 23
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims description 23
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 22
- GTRPODKMSBFDOI-UHFFFAOYSA-N Protopine Natural products CN1Cc2c3OCOc3ccc2C4C1Cc5cc6OCOc6cc5C4=O GTRPODKMSBFDOI-UHFFFAOYSA-N 0.000 claims description 22
- ZAALQOFZFANFTF-UHFFFAOYSA-N Pseudoprotipine Natural products C1=C2C(=O)CC3=CC=4OCOC=4C=C3CN(C)CCC2=CC2=C1OCO2 ZAALQOFZFANFTF-UHFFFAOYSA-N 0.000 claims description 22
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 22
- CHWPMFMUQATVNK-ARYYTZDLSA-N dihydrosporogen AO-1 Natural products O[C@H]1[C@]2(C(C)=C)O[C@@H]2[C@]2(C)[C@@H](C)[C@H](O)CCC2=C1 CHWPMFMUQATVNK-ARYYTZDLSA-N 0.000 claims description 22
- 229910052725 zinc Inorganic materials 0.000 claims description 22
- 241000218671 Ephedra Species 0.000 claims description 21
- 241000234314 Zingiber Species 0.000 claims description 20
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 20
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 20
- 235000008397 ginger Nutrition 0.000 claims description 20
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 19
- 240000004371 Panax ginseng Species 0.000 claims description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 19
- 235000016787 Piper methysticum Nutrition 0.000 claims description 19
- 240000005546 Piper methysticum Species 0.000 claims description 19
- 235000008434 ginseng Nutrition 0.000 claims description 19
- 235000001258 Cinchona calisaya Nutrition 0.000 claims description 18
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 claims description 18
- 235000013336 milk Nutrition 0.000 claims description 18
- 210000004080 milk Anatomy 0.000 claims description 18
- 229960000948 quinine Drugs 0.000 claims description 18
- INPQIVHQSQUEAJ-UHFFFAOYSA-N 5-fluorotryptophan Chemical compound C1=C(F)C=C2C(CC(N)C(O)=O)=CNC2=C1 INPQIVHQSQUEAJ-UHFFFAOYSA-N 0.000 claims description 17
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 claims description 17
- 229940000681 5-hydroxytryptophan Drugs 0.000 claims description 17
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 17
- 229930091371 Fructose Natural products 0.000 claims description 17
- 239000005715 Fructose Substances 0.000 claims description 17
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 17
- 239000008267 milk Substances 0.000 claims description 17
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 claims description 17
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 16
- 229940060736 chromium polynicotinate Drugs 0.000 claims description 16
- 229940076279 serotonin Drugs 0.000 claims description 16
- 235000015192 vegetable juice Nutrition 0.000 claims description 16
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 15
- 241001293495 Lactuca virosa Species 0.000 claims description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 15
- 229940046374 chromium picolinate Drugs 0.000 claims description 15
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 claims description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims description 14
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 14
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 14
- 240000001851 Artemisia dracunculus Species 0.000 claims description 14
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 14
- 244000228088 Cola acuminata Species 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 14
- 229930006000 Sucrose Natural products 0.000 claims description 14
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 14
- 244000269722 Thea sinensis Species 0.000 claims description 14
- 239000001138 artemisia absinthium Substances 0.000 claims description 14
- 239000000796 flavoring agent Substances 0.000 claims description 14
- 235000019634 flavors Nutrition 0.000 claims description 14
- 239000008103 glucose Substances 0.000 claims description 14
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 14
- 239000005720 sucrose Substances 0.000 claims description 14
- OWNRRUFOJXFKCU-UHFFFAOYSA-N Bromadiolone Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1C(O)CC(C=1C(OC2=CC=CC=C2C=1O)=O)C1=CC=CC=C1 OWNRRUFOJXFKCU-UHFFFAOYSA-N 0.000 claims description 13
- 241001071795 Gentiana Species 0.000 claims description 13
- 244000021273 Peumus boldus Species 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 13
- 235000009569 green tea Nutrition 0.000 claims description 13
- 235000016709 nutrition Nutrition 0.000 claims description 13
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 claims description 13
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 claims description 13
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 claims description 13
- 229960001327 pyridoxal phosphate Drugs 0.000 claims description 13
- YMEXGEAJNZRQEH-UHFFFAOYSA-N 6-Fluoro-DL-tryptophan Chemical compound FC1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 YMEXGEAJNZRQEH-UHFFFAOYSA-N 0.000 claims description 12
- 235000002567 Capsicum annuum Nutrition 0.000 claims description 12
- 240000004160 Capsicum annuum Species 0.000 claims description 12
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 12
- 240000007594 Oryza sativa Species 0.000 claims description 12
- 235000007164 Oryza sativa Nutrition 0.000 claims description 12
- 239000003623 enhancer Substances 0.000 claims description 12
- 235000003599 food sweetener Nutrition 0.000 claims description 12
- 239000003765 sweetening agent Substances 0.000 claims description 12
- 229960000278 theophylline Drugs 0.000 claims description 12
- 230000036642 wellbeing Effects 0.000 claims description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 11
- 235000007189 Oryza longistaminata Nutrition 0.000 claims description 11
- 235000000556 Paullinia cupana Nutrition 0.000 claims description 11
- 240000003444 Paullinia cupana Species 0.000 claims description 11
- 241000245665 Taraxacum Species 0.000 claims description 11
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 11
- 239000011575 calcium Substances 0.000 claims description 11
- 229910052791 calcium Inorganic materials 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 229960004441 tyrosine Drugs 0.000 claims description 11
- 229930182816 L-glutamine Natural products 0.000 claims description 10
- 235000010841 Silybum marianum Nutrition 0.000 claims description 10
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 9
- 235000005979 Citrus limon Nutrition 0.000 claims description 9
- 244000131522 Citrus pyriformis Species 0.000 claims description 9
- 206010016334 Feeling hot Diseases 0.000 claims description 9
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 9
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 9
- 230000008901 benefit Effects 0.000 claims description 9
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 9
- 229960001231 choline Drugs 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 9
- 229960000367 inositol Drugs 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000001630 malic acid Substances 0.000 claims description 9
- 235000011090 malic acid Nutrition 0.000 claims description 9
- -1 phospho Chemical class 0.000 claims description 9
- 229950010450 pseudophedrine Drugs 0.000 claims description 9
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 9
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims description 8
- 229930182837 (R)-adrenaline Natural products 0.000 claims description 8
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 8
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 claims description 8
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 239000011651 chromium Substances 0.000 claims description 8
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 8
- 235000018417 cysteine Nutrition 0.000 claims description 8
- 229960005139 epinephrine Drugs 0.000 claims description 8
- 235000008524 evening primrose extract Nutrition 0.000 claims description 8
- 229940089020 evening primrose oil Drugs 0.000 claims description 8
- 239000010475 evening primrose oil Substances 0.000 claims description 8
- 235000019534 high fructose corn syrup Nutrition 0.000 claims description 8
- 229940096421 milk thistle extract Drugs 0.000 claims description 8
- 235000020727 milk thistle extract Nutrition 0.000 claims description 8
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 7
- 240000002045 Guettarda speciosa Species 0.000 claims description 7
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- 235000015422 Rumex crispus ssp. crispus Nutrition 0.000 claims description 7
- 235000015426 Rumex crispus ssp. fauriei Nutrition 0.000 claims description 7
- 244000207667 Rumex vesicarius Species 0.000 claims description 7
- 229910052804 chromium Inorganic materials 0.000 claims description 7
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 229960002179 ephedrine Drugs 0.000 claims description 7
- 239000010452 phosphate Substances 0.000 claims description 7
- 240000000073 Achillea millefolium Species 0.000 claims description 6
- 235000007754 Achillea millefolium Nutrition 0.000 claims description 6
- 244000205574 Acorus calamus Species 0.000 claims description 6
- 235000011996 Calamus deerratus Nutrition 0.000 claims description 6
- 235000005747 Carum carvi Nutrition 0.000 claims description 6
- 240000000467 Carum carvi Species 0.000 claims description 6
- 240000003538 Chamaemelum nobile Species 0.000 claims description 6
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 6
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 6
- 244000183685 Citrus aurantium Species 0.000 claims description 6
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 6
- 235000007856 Cnicus benedictus Nutrition 0.000 claims description 6
- 244000155563 Cnicus benedictus Species 0.000 claims description 6
- 235000008227 Illicium verum Nutrition 0.000 claims description 6
- 240000007232 Illicium verum Species 0.000 claims description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 6
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 6
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 6
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 6
- 244000062730 Melissa officinalis Species 0.000 claims description 6
- 244000246386 Mentha pulegium Species 0.000 claims description 6
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 6
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 240000003085 Quassia amara Species 0.000 claims description 6
- 235000009694 Quassia amara Nutrition 0.000 claims description 6
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 6
- 240000007164 Salvia officinalis Species 0.000 claims description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 6
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 6
- 240000002657 Thymus vulgaris Species 0.000 claims description 6
- 235000009206 Turnera diffusa Nutrition 0.000 claims description 6
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 6
- XSXCZNVKFKNLPR-SDQBBNPISA-N carbazochrome Chemical compound NC(=O)N/N=C/1C(=O)C=C2N(C)CC(O)C2=C\1 XSXCZNVKFKNLPR-SDQBBNPISA-N 0.000 claims description 6
- 235000017803 cinnamon Nutrition 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 6
- 235000020688 green tea extract Nutrition 0.000 claims description 6
- 235000001050 hortel pimenta Nutrition 0.000 claims description 6
- 239000000865 liniment Substances 0.000 claims description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 6
- 235000020778 linoleic acid Nutrition 0.000 claims description 6
- 229940013788 quassia Drugs 0.000 claims description 6
- 235000005412 red sage Nutrition 0.000 claims description 6
- 239000011669 selenium Substances 0.000 claims description 6
- 229910052711 selenium Inorganic materials 0.000 claims description 6
- 239000001585 thymus vulgaris Substances 0.000 claims description 6
- 235000013311 vegetables Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 229940032991 zinc picolinate Drugs 0.000 claims description 6
- NHVUUBRKFZWXRN-UHFFFAOYSA-L zinc;pyridine-2-carboxylate Chemical compound C=1C=CC=NC=1C(=O)O[Zn]OC(=O)C1=CC=CC=N1 NHVUUBRKFZWXRN-UHFFFAOYSA-L 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- 244000061520 Angelica archangelica Species 0.000 claims description 5
- 241000167854 Bourreria succulenta Species 0.000 claims description 5
- 235000021513 Cinchona Nutrition 0.000 claims description 5
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 claims description 5
- 229930182832 D-phenylalanine Natural products 0.000 claims description 5
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 5
- 244000194101 Ginkgo biloba Species 0.000 claims description 5
- 235000004185 Hyptis suaveolens Nutrition 0.000 claims description 5
- 235000002598 Inula helenium Nutrition 0.000 claims description 5
- 244000116484 Inula helenium Species 0.000 claims description 5
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 5
- 235000011430 Malus pumila Nutrition 0.000 claims description 5
- 235000015103 Malus silvestris Nutrition 0.000 claims description 5
- 244000137850 Marrubium vulgare Species 0.000 claims description 5
- 235000005321 Marrubium vulgare Nutrition 0.000 claims description 5
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 5
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 5
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 5
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 5
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 5
- 240000006365 Vitis vinifera Species 0.000 claims description 5
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 5
- 229960004308 acetylcysteine Drugs 0.000 claims description 5
- NHWZQIYTQZEOSJ-UHFFFAOYSA-N carbonic acid;phosphoric acid Chemical compound OC(O)=O.OP(O)(O)=O NHWZQIYTQZEOSJ-UHFFFAOYSA-N 0.000 claims description 5
- 235000019693 cherries Nutrition 0.000 claims description 5
- 235000015165 citric acid Nutrition 0.000 claims description 5
- 235000004634 cranberry Nutrition 0.000 claims description 5
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 5
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 5
- 229940094952 green tea extract Drugs 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 239000000787 lecithin Substances 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 210000003516 pericardium Anatomy 0.000 claims description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 4
- 244000144730 Amygdalus persica Species 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N Glutamine Chemical compound OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 4
- 235000011779 Menyanthes trifoliata Nutrition 0.000 claims description 4
- 240000008821 Menyanthes trifoliata Species 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 4
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims description 4
- 241000320380 Silybum Species 0.000 claims description 4
- 244000223014 Syzygium aromaticum Species 0.000 claims description 4
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 4
- 235000013734 beta-carotene Nutrition 0.000 claims description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 4
- 239000011648 beta-carotene Substances 0.000 claims description 4
- 229960002747 betacarotene Drugs 0.000 claims description 4
- 229940098330 gamma linoleic acid Drugs 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 235000019226 kombucha tea Nutrition 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims description 4
- 230000001953 sensory effect Effects 0.000 claims description 4
- 235000020357 syrup Nutrition 0.000 claims description 4
- 239000006188 syrup Substances 0.000 claims description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- 244000099147 Ananas comosus Species 0.000 claims description 3
- 235000007119 Ananas comosus Nutrition 0.000 claims description 3
- 240000006891 Artemisia vulgaris Species 0.000 claims description 3
- 108010011485 Aspartame Proteins 0.000 claims description 3
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 3
- 240000000560 Citrus x paradisi Species 0.000 claims description 3
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 3
- 240000009088 Fragaria x ananassa Species 0.000 claims description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- 240000005561 Musa balbisiana Species 0.000 claims description 3
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 3
- 235000014443 Pyrus communis Nutrition 0.000 claims description 3
- 240000001987 Pyrus communis Species 0.000 claims description 3
- 235000017848 Rubus fruticosus Nutrition 0.000 claims description 3
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 3
- 240000006909 Tilia x europaea Species 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical group OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 239000004571 lime Substances 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 229960004559 theobromine Drugs 0.000 claims description 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims description 2
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims description 2
- 229960004245 silymarin Drugs 0.000 claims description 2
- 235000017700 silymarin Nutrition 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims 89
- SGPGESCZOCHFCL-UHFFFAOYSA-N Tilisolol hydrochloride Chemical group [Cl-].C1=CC=C2C(=O)N(C)C=C(OCC(O)C[NH2+]C(C)(C)C)C2=C1 SGPGESCZOCHFCL-UHFFFAOYSA-N 0.000 claims 13
- 241000546188 Hypericum Species 0.000 claims 10
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 claims 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 3
- 240000004658 Medicago sativa Species 0.000 claims 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims 2
- 229930182830 galactose Natural products 0.000 claims 2
- 125000003410 quininyl group Chemical group 0.000 claims 2
- 235000019204 saccharin Nutrition 0.000 claims 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims 2
- 229940081974 saccharin Drugs 0.000 claims 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 2
- HHBOUFYYHJJTNU-UHFFFAOYSA-N 1,3,6-thiadiazepane-2,7-dithione Chemical compound S=C1NCCNC(=S)S1 HHBOUFYYHJJTNU-UHFFFAOYSA-N 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- 241000208822 Lactuca Species 0.000 claims 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims 1
- 240000008042 Zea mays Species 0.000 claims 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims 1
- 125000005586 carbonic acid group Chemical group 0.000 claims 1
- 235000005822 corn Nutrition 0.000 claims 1
- 229960000304 folic acid Drugs 0.000 claims 1
- 235000019152 folic acid Nutrition 0.000 claims 1
- 239000011724 folic acid Substances 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 229960003080 taurine Drugs 0.000 claims 1
- 150000003752 zinc compounds Chemical class 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 description 25
- 230000000694 effects Effects 0.000 description 13
- 235000016804 zinc Nutrition 0.000 description 13
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 235000001055 magnesium Nutrition 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
- 244000141009 Hypericum perforatum Species 0.000 description 6
- 230000004800 psychological effect Effects 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 235000016795 Cola Nutrition 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 241000219823 Medicago Species 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 239000004201 L-cysteine Substances 0.000 description 3
- 235000013878 L-cysteine Nutrition 0.000 description 3
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 3
- 229930003571 Vitamin B5 Natural products 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 229930003448 Vitamin K Natural products 0.000 description 3
- 229960001570 ademetionine Drugs 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 3
- 229960002079 calcium pantothenate Drugs 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 239000007937 lozenge Substances 0.000 description 3
- 239000002831 pharmacologic agent Substances 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000037317 transdermal delivery Effects 0.000 description 3
- 239000011675 vitamin B5 Substances 0.000 description 3
- 235000009492 vitamin B5 Nutrition 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- 229940046010 vitamin k Drugs 0.000 description 3
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- RPHLQSHHTJORHI-UHFFFAOYSA-N Adrenochrome Chemical compound O=C1C(=O)C=C2N(C)CC(O)C2=C1 RPHLQSHHTJORHI-UHFFFAOYSA-N 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 2
- 235000010591 Appio Nutrition 0.000 description 2
- 235000011824 Cola pachycarpa Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000000380 hallucinogen Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 239000004081 narcotic agent Substances 0.000 description 2
- 239000000820 nonprescription drug Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000955 prescription drug Substances 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N (+)-Erythro-hydroxycitric acid Natural products OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 1
- ZMJBYMUCKBYSCP-AWFVSMACSA-N (1s,2r)-1,2-dihydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)[C@@H](O)[C@@](O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-AWFVSMACSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- RTAPDZBZLSXHQQ-UHFFFAOYSA-N 8-methyl-3,7-dihydropurine-2,6-dione Chemical class N1C(=O)NC(=O)C2=C1N=C(C)N2 RTAPDZBZLSXHQQ-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000010205 Cola acuminata Nutrition 0.000 description 1
- 235000015438 Cola nitida Nutrition 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000892865 Heros Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- PHTXVQQRWJXYPP-UHFFFAOYSA-N ethyltrifluoromethylaminoindane Chemical compound C1=C(C(F)(F)F)C=C2CC(NCC)CC2=C1 PHTXVQQRWJXYPP-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940050549 fiber Drugs 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000000899 immune system response Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 229940106589 milk thistle seed extract Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/362—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- T is application is a co ⁇ tinuation-i ⁇ -part of U.S. Patent Application Serial Nc.
- the invention relates to compositions having a nutritionally beneficial substituent and a substituent that stimulates a short and/or long term psychological feedback and to vehicles or devices that accomplish the deiivei ⁇ of the nutritionally beneficial substituent to a recipient.
- the invention particularly concerns compositions for oral or translingual delivery using beverages, lozenges and the like ?s vehicles to facilitate delivery.
- the invention additionally concerns the use of transdermal delivery devices (e.g., patches) to accomplish the delivery of such substituent(s).
- the invention particularly concerns a formulated, substantially alcohol- free beverage for oral consumption having a nutritionally beneficial substituent and a substituent that stimulates psychological feedback and which accomplishes the oral delivery of the nutritionally beneficial substituent.
- U.S. Patent 5,626,849 (Hastings et al.) concerns a composition for facilitating weight loss.
- the composition contains chromium, L-carnitine, ⁇ -linolenic acid, (-) hydroxycitric acid, choline, inositol, antioxidants and herbs.
- U.S. Patent 5,567,424 (Hastings) describes a beverage composition containing herbs, fiber, antioxidants and enzymes.
- U.S. Patent 5,536,506 (Majeed etai.) ⁇ esc ⁇ bes pipe ⁇ ne-co ⁇ taini ⁇ g compositions.
- U.S. Patent 5,536,506 (Majeed etai.) ⁇ esc ⁇ bes pipe ⁇ ne-co ⁇ taini ⁇ g compositions.
- Patent 5,290,505 (Shapira) concerns a nutritional soft d ⁇ nk whose ingredients are said to provide protection from UV damage.
- the comcosition contains a carotenoid mix and ODtionally, fruit/vegetable juices and/or herbal preparations.
- U.S. Patent 5,240,732 (Ueda) concerns plant extract-containing beverages supplemented with a sugar-alcohol.
- U.S. Patents 5,681,569 (Kuznicki et al.) and 4,946,701 (Tsai et al.) both concern beverage compositions that contain green tea extracts.
- U.S. Patent 5,574,522 (Shan et al.) concerns a powdered concentrate containing one or more pharmacologically active agents for use in hot beverages. The composition may contain caffeine, as well as vitamins and minerals.
- U.S. Patent 5,571,- 4 41 is directed to nut ⁇ tional supplements comDOSitions that provide psychological feedback.
- compositions contain vitamins and/or minerals as well as xanthine alkaloids (such as caffeine, etc.) that provide a physiological signal.
- U.S. Patent 5,114,723 (Stray-Gundersen) concerns hypotonic beverages for supplying physiologically essential electrolytes, nutrient minerals, carbohydrates and other ingredients to a consume r The patent discloses that caffeine may be added to the beverage formulation.
- U.S Patent 4,992,282 (Mehansho et al.) concerns vitamin and mineral-fortified beverages, which may be supplemented with caffeine.
- U.S. Patent 4,512,205 (KupDer et al) concerns fruit-flavored carbonated beverages that may be supplemented with caffeine
- U.S. Patent 4,061,797 U.S. Patent 4,061,797
- U.S. Patent 4,737,375 (Nakel etal) describes calcium-supplemented beverages.
- U S. Patent 4,769,244 (Lavie) describes non-hygroscopic water-soluble pulverulent compositions that may be employed to make beverages. Compositions for accomplishing transdermal delivery of pharmaceuticals have also been described (see, for example, U.S. Patents 5,718,914 (Foldva ⁇ ), 5,698,217 (Wilking), 5,721,257 (Baker), 5,683,713 (Blank etal.), and 4,788,189 (Glazer)).
- the present invention provides an improved composition for accomplishing the delivery of nutritionally beneficial substituents.
- the present invention additionally provides an improved formulated beverage that provides at least one, and most preferably multiple, short and long term psychological feedback(s) to the consumer SUMMARY OF THE INVENTION:
- the present invention provides beverages and other compositions that are formulated to provide internal appeal directly to the brain (i.e., brain rewards).
- the present invention thus relates to a formulated, defined composition having a nutritionally beneficial substituent and a long and/or short term substituent that stimulates psychological feedback and to vehicles or devices that accomplish the delivery of the nutritionally beneficial substituent.
- Such preferred compositions will typically possess a nutritionally beneficial substituent and both a long term and a short term substituent that stimulates psychological feedback and which accomplishes the delivery of the nutritionally beneficial substituent.
- Preferred vehicles include oral and/or translingual delivery vehicles, such as beverages, elixirs, lozenges, chewable tablets, and the like, and transdermal delivery devices such as patches, bandages, etc.
- composition preferably a formulated beverage (most preferably, substantially alcohol-free) for oral human consumption having a defined composition of substituents comprising: at least one nutritionally beneficial substituent (A) selected from the group consisting of:
- L-cysteine and L-methionine S-adenosylmethionine; green tea; guarana; hops; inositol; iron; kava kava; kombucha tea; kudzu; lobelia; glutamic acid; D-phenylalanine; DL-phenylalanine; L-tyrosine; lecithin; linoleic acid; gamma- linoleic acid; magnesium; milk thistle extract (silymari ⁇ ); niacin; PABA; protopine; puerarin; pyridoxal-5-phosphate; selenium; soluble fiber; St.
- compositions that additionally contain at least one additional substituent (C) that provides long term psychological feedback and/or at least one additional substituent (D) that provides short term psychological feedback; wherein the substituent (C) that provides the long term psychological feedback is selected from the group consisting of: an anandamide; 5-hydroxytryptophan; 5-fluoro-A-methyltryptamine; 5- fluorotryptophan; 6-fluorotryptophan; tryptophan; allocryptine; caffeine; theophylline; theobromine; California poppy; calcium; chromium picolinate; chromium polynicotinate; chicalote extract; cocoa; chocolate; Damiana ( Tur ⁇ era diffusa); DL-phenylalanine; ephedra; ephedrine; epinephrine; GABA; ginger; ginseng; L-glutamine; green tea; guarana; kava kava; lactuca virosa; L-
- Johnswort and is present in an amount sufficient to provide a long term feeling of well-being or calmness; and the substituent (D) that provides the short term psychological feedback is selected from the group consisting of: an anandamide; an alcohol enhancer; angelica root; balm; bitter orange (Auranti pericarpium); bogbean; boldo; calamus; California poppy; capsaicum; caraway; cayenne; chamomile; cinchona bark; quinine; chocolate; cinnamon; clove; cocoa; condurango; dandelion; elecampane; GABA; gentian; ginger; ginseng; holy thistle; hops; horehound; dried lemon peel (Ctrl ericardium); mugwcrt; unripe orange; peppermint; quassia; red sage; rosemary; star anise; thyme; tumeric; wormwood; yarrow; and zinc; and is present in an amount sufficient to provide a short term sensation of
- the invention additionally provides a composition for human consumption, comprising: at least one nutritionally beneficial substituent, the substituent being present in an amount sufficient to provide a nutritional benefit to the human recipient; and at least one additional substituent (C) that provides long term psychological feedback substituent or at least one additional substituent (D) that provides short term psychological feedback; wherein the substituent (C) that provides the long term psychological feedback is selected from the group consisting of: an anandamide; 5-hydroxytryptopha ⁇ ; 5-fluoro-A-methyltryptamine; 5- fiuorotryptophan; 6-fluorotryptophan; tryptophan; allocryptine; caffeine; theophylline; theobromine; California poppy; calcium; chromium picolinate; chromium polynicotinate; chicalote extract; cocoa; chocolate; Damiana (Turnera diffusa); DL-phenylalanine; ephedra; ephedrine; epinephrine; GABA; ginger; gins
- Johnswort and is present in an amount sufficient to provide a long term feeling of well- being or calmness; and the substituent (D) that provides the short term psychological feedback is selected from the group consisting of: an anandamide; an alcohol enhancer; angelica root; balm; bitter orange (Aurantl pericarpium); bogbean; boldo; calamus; California poppy; capsaicum; caraway; cayenne; chamomile; cinchona bark; quinine; chocolate; cinnamon; clove; cocoa; condurango; dandelion; elecampane; GABA; gentian; ginger; ginseng; holy thistle; hops; horehound; dried lemon peel (CM pericardium); mugwort; unripe orange; peppermint; quassia; red sage; rosemary; star anise; thyme; tumeric; wormwood; yarrow; and zinc; and is present in an amount sufficient to provide a short term sensation of warmth, tingling,
- the invention additionally provides a method for providing a nutritionally beneficial substituent (A) to a human, comprising administering or providing to the human a composition containing: the nutritionally beneficial substituent (A) in an amount sufficient to provide the nutritional benefit to the human recipient; and at least one additional substituent (C) that provides long term psychological feedback substituent or at least one additional substituent (D) that provides short term psychological feedback; wherein the substituent (C) that provides the long term psychological feedback is selected from the group consisting of: an anandamide; 5-hydroxytryptophan; 5-fluoro-A-methyltryptamine; 5- fluorotryptophan; 6-fluorotryptophan; tryptophan; allocryptine; caffeine; theophylline; theobromine; California poppy; calcium; chromium picolinate; chromium polynicotinate; chicaicte extract; cocoa; chocolate; Damia ⁇ a ( Turnera diffusa); DL-phenylalanine; ephedra; ephedrin
- Johnswort and is present in an amount sufficient to provide a long term feeling of well- being or calmness; and the substituent (D) that provides the short term psychological feedback is selected from the group consisting of: an anandamide; an alcohol enhancer; angelica root; balm; bitter orange (Auranti pericarpium); bogbean; boldo; calamus; California poppy; capsaicum; caraway; cayenne; chamomile; ⁇ ncho ⁇ a bark; quinine; chocolate; cinnamon; dove; cocoa; condurango; dandelion; elecampane; GABA; gentian; ginger; ginseng; holy thistle; hops; horehound; dried lemon peel (Gt ⁇ pericardium); mug ort; un ⁇ pe orange; peppermint; quassia; red sage; rosemary; star anise; thyme; tume ⁇ c; wormwood; yarrow; and zinc; and is present in an amount sufficient to provide a short term sensation of
- the invention also provides a composition for human consumption, comprising two, three, four or five nutritionally beneficial substituents (A) selected from the group consisting of adrenochrome semicarbazone; 5-hydroytryptophan; 5-fluoro-A- methyltryptamine; 5-fluoro-tryptopha ⁇ ; 6-fluorotryptophan, tryptophan; acetosalycilic acid; ibuDrophen; acetaminophen; alfalfa; ailocryotine; beta- carotene; calcium; caffeine; theophylline; theobromine, choline, chromium picolinate; chromium polynicotinate, diadzin; diadzein, damiana; turnera diffusa; dandelion; evening primrose oil; foiic aod; GABA, ginger; ginkgo biloba; ginseng; glutathione; cysteine; L-glutamine; gly ⁇ ne
- the invention also provides a composition for human consumption, comprising two, three, four or five nutritionally beneficial substituents (C) that provide long term psychological feedback, wherein said nutritionally beneficial substituents (C) are selected from the group consisting of an a ⁇ an ⁇ amide; 5-nydroxytryptophan; 5-fIuoro-A-methyitryptam ⁇ ne; 5- fluoratryptophan; 6-fIuorotryptophan; tryptophan; allc ⁇ yptine; caffeine; theoDhylli ⁇ e; theobrom e; California poopv; cal ⁇ um; chromium picolinate; chromium polynicotinate; chicalote extract; cocoa; chocolate; Damiana ( Tumera dlff ⁇ sa); DL-phenylalanine; ephedra; ephed ⁇ ne; epmeph ⁇ ne;
- GABA GABA
- ginger ginseng; L-glutamine; green tea; guarana; kava kava; lactuca virosa; L-tyrosine; lobelia; magnesium; maraba; protopi ⁇ e; pseudophed ⁇ ne; pseudoepineoh ⁇ ne; py ⁇ doxal-5-phosphate; red ⁇ ce yeast; serotonin; sucrose; fructose; glucose; high fructose corn syrup; and St. Jonnswort.
- the invention relates to formulated, defined compositions having a nutritionally beneficial substituent and a long and/or short term substituent that stimulates psychological feedback, oDttonally in comDination with a substituent that provides a traditional psychological feedback.
- the invention further relates to vehicles cr cevices that accomplish the delivery of the composition to a recipient.
- the invention concerns such formulated, defined compositions that contain both a short term and a long term substituent that stimulates psychological feedback.
- Some imcortant conditions e.g., alcohol and drug aouse, etc.
- imcortant conditions e.g., alcohol and drug aouse, etc.
- individuals who may suffer from denial, and do not want to admit to the existence of a problem By providing positive psychological feedbacks and multiple benefits common to the class, such individuals can be encouraged to imDrove their nutrition for some of the combination of nutritional benefits, without having to face their psychological problems, and thus, as an unintended consequence, be exposed to the proper nutrition for the long term solution to their major problems.
- compositions of the present invention are formulated or included in vehicles or devices that accomplish their delivery to recipients, and in particular, to recipient humans.
- a translingual deliver/ vehicle is one a that accomplishes the delivery of the composition via adsorbtion into the tongue, gums or soft tissues of the oral cavity
- a vehicle suitable for oral delivery is one that accomplishes the delivery of the composition after ingesti ' on.
- Oral and translingual/transdermal vehicles indude beverages, lozenges, elixirs, syrups, powders, candies, chewable tabiets, etc.
- the delivery of the compositions of the present invention is accomplished using a transdermai delivery device.
- a transdermai delivery device Such devices indude bandages, patches, implants, etc. that accomplish the delivery of substituents via adsorption through the skin.
- compositions of the present invention are said to be "formulated, defined compositions" by which it is meant that at least two, and preferably all, of their chemical substituents are substantially defined chemically.
- the compositions of the present invention may contain undefined substituents, such as those found in naturally obtainable plant extracts, etc., in all instances they contain at least two chemically asc ⁇ rtainable substituents that were deliberately added to the composition in predetermined amounts to achieve preselected concentrations.
- the amounts of such substituents in the compositions of the invention will preferably be determined with consideration of the functional concentration (potency) of the substituent.
- Beverages for oral administration are the preferred delivery vehicle.
- the term "beverage” is intended to refer to a liquid composition that is in "single” strength form and is ready to drink. Examples of beverage compositions are well known (see, U.S. Patents 4,737,375 (Nak ⁇ i et al.), 4, 992,252 (Mehans ⁇ o et a!.), 5,583,578 (Heckert et a!.), 5,571,441 (Andcn etal.), each herein incorporated by reference).
- the invention contemplates the formulation and use of such beverages, as well as the formulation and use of beverage "concentrates.”
- concentrates include solid materials (capsules, tablets, powders, etc.) or solutions, suspensions, or other liquids that require dilution before attaining their desired final state.
- Such liquid compositions may be formulated from the dissolution or suspension of solid substituents, or from the mixing of liquid substituents, or both.
- the liquid compositions of the present invention are intended to be orally provided, as distinguished from intravenous or other means.
- the beverages of the present invention may be imbibed cooled (as by a refrigerant), or at ambient or elevated temperature (i.e., from about 25 °C to about 180 °C) or at more elevated temperatures (i.e., as a "hot" drink).
- the beverages of the present invention are imbibed at temperatures below 180 °C.
- the beverages of the present invention are imbibed at temperatures below 25 °C.
- the beverages of the present invention are preferably aicohol-free. They thus contain less than about 10% ethanol, more preferably less than about 5% ethanol, and most preferably are alcohol-free (i.e. only a trace amount of ethanol or none at all).
- the beverages of the present invention may be alcohol-containing beverages (i.e., a beverage having between about 10% and aDout 40% aicohol).
- the beverages of the present invention may be either carbonated or non-carbonated.
- carbonated means that the beverage contains both dissolved and dispersed carbon dioxide.
- Methods of forming carbonated beverages are well known in the art (see, for example, U.S. Patent 4,946,701 (Tsai etal.).
- the beverages of the present invention will contain from 1.0 to about 4.5 volumes of carbon dioxide.
- the preferred carbon dioxide beverages contain from about 2 to about 3.5 volumes of carbon dioxide.
- compositions of the present invention contain at least one substituent selected from a first class of substituents that comprise nutritionally beneficial compounds. Any of a wide array of such substituents may be included in the compositions of the invention.
- a beverage designed for individuals exhibiting the effects of alconol, or the effects of mood altering prescription or non-prescription drugs may contain substituents that may replace depleted nutrients (such as vitamins, minerals, etc.); serve as antioxi ⁇ ants; improve or repair brain function (e.g., memory, learning, etc.); suppress appetite or alcohol desire; reverse alcohol-related damage; alleviate stress; improve virility; improve or repair liver function, improve or repair immune system responses, alleviate depression; improve or repair blood functions (e.g., oxygen transport, blood sugar level stabilizers, metabolite transport, detoxification, ion balance, etc.).
- compositions of the present invention contain at least one, and more preferably 2 or more substituents of this first class.
- Preferred substituents of this first class, their associated function, and their preferred concentrations ..i the compositions of the present invention are described in Table A. In Table A,
- a substituent is indicated to have multiple associated functions, the same concentration of substituent provides all functions, unless a separate dosage is indicated.
- a substituent is to be provided at a recited concentration, which is the preferred daily intake amount of the substituent
- the daily intake amount may be obtained by a single serving, etc.,, or by multiple servings, etc..
- the daily intake amount will be delivered in three servings, each comp ⁇ sing one third of the total preferred intake amount
- the amount/day shown is the most preferred amount per day, unless a maximum, more preferred and/or most preferred amount day is indicated. Where no amount/day is provided, the substituent may be provided in any customary or traditional amount/day.
- compositions of the invention will contain one or more sucn preferred nutritionally beneficial substituents, such more preferred substituents being selected from the group consisting of: Adrenochrome Semicaraazone; 5-hydroytryptocnan or equivalent compounds (e.g.; 5-fluoro-A-methyltryptam ⁇ ne; 5-fluorotryptophan; 6-fluorotryptopnan; tryptoDhan; etc.); Allocrypti ⁇ e; Choline; Diadzin; Diadzein; Damia ⁇ a Turnera Diffusa; Evening Primrose Oil; Giutathione or Giutathione equivalents (e.g.; cysteine; L-glutamine; giycine); Other Giutathione Equivalents: N-acetylcysteine (NAC); L-cysteine - • - L-methionine; S- adenosyimethi
- compositions of the invention will contain one or more such preferred nutritionally beneficial substituents, such highly preferred substituents being selected from the group consisting of: Adrenochrome Semicarbazone; 5-hydroytryptophan or e ⁇ uivalent compounds (e.g.; 5-fluoro-A-methyltryptamine; 5-fluorotryptophan; 6-fiuorotryptophan; tryptophan; etc.); Allocryptine; Diadzin; Diadzein; Evening Primrose Oil; Other Giutathione Equivalents: N-ac ⁇ tylcysteine (NAC); L-cysteine + L-methionine; S-adenosylmethionine (SAMe); Kudzu; Lobelia; Milk Thistle Extract (Silymarin); Niacin; Protopi ⁇ e; and Puerarin.
- Adrenochrome Semicarbazone 5-hydroytryptophan or e ⁇ uivalent compounds (e.g.; 5-fluoro-
- compositions of the invention may contain at least one substituent selected from a second class of substituents that provide a traditional psychological feedback. Any of a wide array of such substituents may be included in the composition. Such substituents will impart a sensory psychological effect to the recipient, such as a pleasant taste, aroma, visual appeal, etc.
- the compositions of the invention may contain more than one such traditional psychological feedback substituent. Tabie B lists preferred traditional psychological feedback substituents that may be employed in the compositions of the present invention to impart such psychological effect.
- Sweetener such as calo ⁇ c sweeteners (e.g., fructose, high fructose com syrup, su ⁇ ose, maltose, glucose, lactose, sorbitoi, gaiactose, etc.) or substantially non-caloric sweeteners (e.g., aspartame (and its de ⁇ va ⁇ ves). saccha ⁇ n, L-suqars. cyclamates, etc.)
- calo ⁇ c sweeteners e.g., fructose, high fructose com syrup, su ⁇ ose, maltose, glucose, lactose, sorbitoi, gaiactose, etc.
- substantially non-caloric sweeteners e.g., aspartame (and its de ⁇ va ⁇ ves). saccha ⁇ n, L-suqars. cyclamates, etc.
- Fruit j uice or juice extract such as no ⁇ - ⁇ trus fruit juices or juice extracs (e.g., those obtainable from apple, pineapple, grape, pear, banana, pium, cherry, peach, etc.); oerry fruit juices or juice extracts (sucn as those obtainable from strawberry, blueberry, cranberry, blackberry, etc.); or ⁇ trus fruit juices or juice extracts (such as those obtainaole from orange, grapefruit, lemon, lime, etc.)
- no ⁇ - ⁇ trus fruit juices or juice extracs e.g., those obtainable from apple, pineapple, grape, pear, banana, pium, cherry, peach, etc.
- oerry fruit juices or juice extracts sucn as those obtainable from strawberry, blueberry, cranberry, blackberry, etc.
- ⁇ trus fruit juices or juice extracts such as those obtainaole from orange, grapefruit, lemon, lime, etc.
- Milk including mammalian milk products such as skim milk and cream, and vegetable milks, such as sov milk.
- Vegetable j uices or juice extracts (such as those obtainable from carrot, tomato, beets, celerv, etc.) kudzu j 5-hydroxy-trvPt ⁇ Phan
- Spices and plant extract flavo ⁇ ngs such as cola, ginger, nutmeg, cecos r vanilla, cnccclate. "ur *** , mint, sugar rn aole. heros, etc. ) .
- Synthetically compounded flavorants or naturally isolated flavorants may be employed as such traditional psychological feedback substtuents.
- compositions of the present invention may be formulated to contain green tea extract.
- Green tea helps to control the negative effects of caffeine. See, for example, French patent No. 2,586,532 issued to
- compositions of the present invention will contain one or more preferred traditional psychological feedback substituents, such more preferred substituents being selected from the group consisting of: Caffeine and caffeine equivalents (e.g.; theophylline; theobromine; related methylxanthines); cola; carbonic acid; phosphoric acid; citric acid; hops; cocoa; chocolate; anandamide; quinine; maiic acid; non-citric fruit juice or juice extract (such as wherein the fruit is grape; apple; cranberry; cherry; peach; etc.); milk; vegetable juice or juice extract (such as wherein the vegetable is carrot; celery; etc.); kudzu; and 5-hydroxy-tryptophan.
- Caffeine and caffeine equivalents e.g.; theophylline; theobromine; related methylxanthines
- cola carbonic acid
- phosphoric acid citric acid
- hops cocoa
- chocolate anandamide
- quinine maiic acid
- compositions cf the present invention will contain one or more highly preferred traditional psychological feedback substituents, such highiy preferred substituents being selected from the group consisting of: Caffeine and caffeine equivalents (e.g.; theoohylline; theobromine; related methylxanthmes) at a concentration/day of greater than about 55 mg; carbonic acid; phosphoric acd; hops; non-cit ⁇ c fruit juice or fruit juice extract (such as wherein the fruit is grape; apple; cranberry; cherry; peach; etc.); milk, vegetable juice or juice extract (such as wherein the vegetable is carrot; celery; etc.); kudzu; and 5-hydroxy-tryptophan.
- Caffeine and caffeine equivalents e.g.; theoohylline; theobromine; related methylxanthmes
- non-cit ⁇ c fruit juice or fruit juice extract such as wherein the fruit is grape; apple; cranberry; cherry; peach; etc.
- compositions of the invention may contain at least one substituent selected from a third class of substituents that provide long term psychological feedback. Any of a wide array of such substituents may be included in the composition. Such substituents will impart a long term psychological effect to the recipient, such as a feeling of warmth or tingling, of excitement, of tranquillity and well-being, etc.
- the compositic is of the invention will contain more than one such long term psychologically active substituent Table C lists particularly preferred long term duration psychological feedback substituents that may be employed in the compos.tiors of the present invention to impart a long e 1 "'! psychological effect
- compositions of the present invention will contain one or more such long term, psychological feedback substituents, such more preferred substituents being selected from the group consisting of: 5-hydroytryptophan or equivalent compounds (e.g.; 5-fluoro-A- methyltryptamine; 5-fluorotryptophan; 6-fIuorotryptophan; tryptophan; etc.); Allocryptine; California Poppy; Chromium (Cr-Picoli ⁇ ate; Cr-Polynicotinate; (Cr amounts increased with amount of Zn present; decreased for amounts of amino acids)); Cocoa; Damiana ( Tur ⁇ era diffusa); D-phenylalanine; Ephedra (especially nevadenis); Ephedri ⁇ e; Epinephrine; GABA; L- giutamine; Green Tea; Kava Kava; Lactuca Virosa; Lobelia; Magnesium; Maraba; Protopine
- 5-hydroytryptophan or equivalent compounds e.g.; 5-fluor
- compositions of the present invention will contain one or more such long term psychological feedback substituents, such highly preferred substituents being selected from the group consisting of: 5-hydroytryptophan or equivalent compounds (e.g.; 5- fluoro-A-methyltryptamine; 5-fluorotryptophan; 5-fluorotryptophan; tryptophan; etc.); Allocryptine; California Poppy; Chicalote Extract (without toxic substituents); Cocoa; Damiana (Tumera diffusa); Ephedra nevadenis; Ephed ⁇ ne; Green Tea; Lactuca Virosa; Lobelia; Maraba; Protopine; Pseudophedrine; Pseudoepinephrine and Red Rice Yeast
- 5-hydroytryptophan or equivalent compounds e.g.; 5- fluoro-A-methyltryptamine; 5-fluorotryptophan; 5-fluorotryptophan; tryptophan; etc.
- Allocryptine California
- compositions of the invention may contain at least one substituent selected from a fourth class of substituents that provide short term psychological feedback. Any of a wide array of such substituents may be included in the composition. Such substituents will impart a short term psychological effect to the recipient, such as a feeling of warmth or tingling, of excitement, of tranquillity and well-being, etc. In a preferred embodiment, the compositions of the invention will contain more than one such short term psychologically active substituent.
- compositions of the invention may contain psychologically active substituents that mediate their respective effects in Doth a short duration (i.e., effect completed within 15 minutes of nutritionally beneficial.) and a long term duration (i.e., effect completed after 15 minutes of nutritionally beneficial).
- Table D lists preferred short term duration psychological feedback substituents that may be employed in the compositions of the present invention to impart a short term psychological effect.
- compositions of the present invention will contain one or more preferred short term psychological feedback substituents, such more preferred substituents being selected from the group consisting of: Anandamide; Alcohol Enhancers, Standard Flavorants; Angelica root; Boldo; California Poppy; Capsaicum; Cayenne; GABA; Gentian; Tume ⁇ c; Vitamin K; and Wormwood.
- preferred substituents being selected from the group consisting of: Anandamide; Alcohol Enhancers, Standard Flavorants; Angelica root; Boldo; California Poppy; Capsaicum; Cayenne; GABA; Gentian; Tume ⁇ c; Vitamin K; and Wormwood.
- compositions of the present invention will contain one or more highly preferred short term psychological feedback substituents, such highly preferred substituents being selected from the group consisting of: an anandamide; an alcohol enhancer; Angelica root; Boldo; California Poppy; Capsaicum; GABA; Gentian; Tumeric; Vitamin K; and Wormwood.
- highly preferred substituents being selected from the group consisting of: an anandamide; an alcohol enhancer; Angelica root; Boldo; California Poppy; Capsaicum; GABA; Gentian; Tumeric; Vitamin K; and Wormwood.
- compositions containing one or more substituents of substituent classes (A) that provide nutritional benefit, (B) that provide traditional psychological feedback, (C) that provide long term psychological feedback, and/or (D) that provide short term psychological feedback.
- the invention specifically contemplates compositions containing at least one substituent of each of the substituent classes: (A), (B), (C) and (D); (A), (B) and (Q; (A), (B) and (D); (A), (C) and (D); (B), (C) and (D); (A) and (B); (A) and (C); (A) and (D); (B) and (C); (B) and (D); and (C) and (D).
- T e invention additionally contemplates preferred compositions containing either one or more of the above-recited mere preferred nutritionally beneficial substituents (A) or one or more of the above-recited highly preferred nutritionally beneficial substituents (A), and one or more of the above-recited preferred long term psychological feedback substituents (B), and one or more of the above-recited preferred short term psychological feedback substituents
- Tne invention additionally contemplates preferred compositions containing one or more of the above-recited preferred nutritionally beneficial substituents (A), and one or more of the above-recited preferred long term psychological feedback substituents (C), and either one or more of the above-recited more preferred short term psychological feedback substituents (D) or one or more of the above-recited highly preferred short term psychological feedback substituents (D).
- the invention additionally contemplates preferred compositions containing one or more of the above-recited preferred nutritionally beneficial substituents (A), and either one or more of the above-recited more preferred long term psychological feedback substituents (C) or one or more of the above-recited highly preferred long term psychological feedback substitue ⁇ ts (C), and one or more of the above-recited preferred short term psychological feedback substituents (D).
- the invention further contemplates more preferred compositions containing one or more of the above-recited more preferred nutritionally benefidal substituents (A), and one or more of the aoove-retited preferred long term psychological feedback substituents (C), and one or more of the above-recited more preferred short term psychological feedback substituents (D).
- the invention further contemplates more preferred compositions containing one or more of the above-recited preferred nutritionally beneficial substituents (A), and one or more of the above-recited more preferred long term psychological feedback substituents (C), and one or more of the above-recited more preferred short term psychological feedback substituents (D).
- the invention further contemplates highly preferred compositions containing one or more of the above-recited highly preferred nutritionally beneficial substituents (A), and one or more of the above-recited preferred long term psychological feedback substituents (C), and one or more of the above-recited highly preferred short term . psychological feedback substituents (D).
- the invention further contemplates highly preferred compositions containing one or mere of the above-recited highly preferred nutritionally beneficial substituents (A), and one or more of the above-recited highly preferred long term psychological feedback substituents (C), and one or more of the above-recited preferred short term psychological feedback substituents (D).
- the invention further contemplates highly preferred compositions containing one or more of the above-recited preferred nutritionally beneficial substituents (A), and one or more of the above-recited highly preferred long term psychological feedback substituents (C), and one or more of the above-recited highly preferred short term psychological feedback substituents (D).
- the invention further contemplates very highly preferred compositions containing one or more of the above-recited highly preferred nutritionally beneficial substituents (A), and one or more of the above-recited highly preferred long term psychological feedback substituents
- compositions of the present invention may additionally contain non-pharmacologicai agents such as stomach acid buffering compounds, antacids, fiber, laxatives, muscle relaxants, analgesics, acetaminophens, ibuprophens, topical antibiotics, anti-inflammatory agents, etc.) at non-prescription levels.
- non-pharmacologicai agents such as stomach acid buffering compounds, antacids, fiber, laxatives, muscle relaxants, analgesics, acetaminophens, ibuprophens, topical antibiotics, anti-inflammatory agents, etc.
- prescription pharmacological agents such as hormones (e.g., insulin, thyroid hormone, etc.), anti- inflammatory agents, hypertensives, anti-arrhythmias, etc.
- compositions of the present invention and such prescription pharmacological agents has the salutary effect of confirming or the consumer's perception or recollection that a dosage has been consumed or administered, and as such aids in preventing overdosing and underdosing by individuals who are self administering such pharmacological agents.
- compositions of the present invention are provided via vehicles for oral or translingual delivery.
- such vehicles are formulated to contain one or more additional substituents selected from the group consisting of: a xanthine alkaloid (such as a methyixanthine (caffeine, theophylline, theobromine, etc.) obtainable synthetically, or by extraction of plants (e.g. coffee beans, cola nuts, tea plants, etc.); carbonic acid, milk, vegetable juice, fruit juice, phosphoric acid, citric acid, hops, cocoa, chocolate, anandamide, quinine and malic acid.
- a xanthine alkaloid such as a methyixanthine (caffeine, theophylline, theobromine, etc.
- a xanthine alkaloid such as a methyixanthine (caffeine, theophylline, theobromine, etc.
- plants e.g. coffee beans, cola nuts, tea plants, etc.
- carbonic acid e.g. coffee beans, cola nuts, tea plants,
- Tne amounts of methyixanthines (and especially caffeine) present in the compositions of the invention are designed to result in the delivery of an amount of such methyixanthines sufficient to impart the desired effect.
- the composition contain compounds that interact (or sequester) such methylxa ⁇ thines, proportionately larger amounts of methyixanthine will be included in the composition.
- the composition contain substituents that enhance the desired effect of a methyixanthine, the amount of the methyixanthine in the composition will be proportionately reduced.
- Serotonin, and its precursors, and substituents that stimulate serotonin production and/or release are also preferred substituents of the compositions of the present invention.
- compositions of the present invention may comprise dear solutions, or may be suspensions of particulate mate ⁇ al (such as plant pulp or other tissue).
- particulate mate ⁇ al such as plant pulp or other tissue.
- beverages When provided as a beverage, such beverages are typically free-flowing and have a viscosity similar to that of water.
- thickening agents are added to impart greater viscosity to the beverages.
- the beverages of the present invention are typically dispensed and stored in containers (e.g., cardboard containers, glass or plastic bottles, metal cans, etc.).
- compositions of the present invention provide a nutritionally beneficial substituent to an individual in a manner accompanied by a reinforcing psychological feedback sensation.
- the psychological feedback sensation imparts an immediate physiological recognition of the composition (such as a feeling of warmth, or a flush feeling) as well as a long term psychological feedback (such as a counter-depressive effect or a sense of well-being).
- These feedbacks become psychologically associated with the nutritional benefit and the therapeutic activity of the composition and increase an individual's desire to take or use the composition on a regular basis, and thus serve to ensure that the in ⁇ ivicual obtains a nutritionally beneficial amount of the composition.
- the compositions of the present invention can be tailored to provide any of a number of desired therapeutic effects.
- Such effects include blood detoxification; liver repair and detoxification; lessening of a desire to drink alcohol; reversal of alcohol-induced damage; antioxidant activity; alleviating depression, alleviating stress, restoring or improving brain function (such as memory and learning capabilities); suppressing appetite; stabilizing blood sugar levels; improving immune system function and response; etc.
- compositions can be formulated to contain effective amounts of nutritionally active substituents (such as vitamins, minerals, co- factors, etc.) which build or restore supplies of such substituents damaged by conditions commonly related to each therapy so as to improve the general health of the recipient.
- nutritionally active substituents such as vitamins, minerals, co- factors, etc.
- compositions of the present invention are formulated to provice a treatment for the conditions associated with alcoholism and/or the effects of mood alte ⁇ ng prescription or non-prescription drugs (e.g., depressants, narcotics, hallucinogens, stimulants, etc.).
- mood alte ⁇ ng prescription or non-prescription drugs e.g., depressants, narcotics, hallucinogens, stimulants, etc.
- compositions, especially beverages are formulated to provide effective amounts of: (1) a liver function reDairant (such as alfalfa, choline, dandelion, gctu kola, .nositol, L-cysteine, L- ethionme, lecithin, milk thistle, nia ⁇ n, selenium, vitamin 31, vitamin D, yellow dock, zinc and or zinc picolinate); (2) a substituent for reversing alcohol- related damage (alfalfa, magnesium, vitamin Bl, vitamin D); (3) a substituent for alleviating stress or depression (such as calcium, choline, folic a ⁇ d, GABA, ginkgo biloba, ginseng, gotu kola, inositol.
- a liver function reDairant such as alfalfa, choline, dandelion, gctu kola, .nositol, L-cysteine, L- ethi
- DL-phenylalanine 5-hydroxy-fryptoohan, le ⁇ thin, magnesium, PABA, vitamin B3, vitamin B5, vitamin B12, vitamin C
- a substituent for reducing the re ⁇ pients desire for alcohol such as daldzin, foiic acid, giutathione, kudzu, l-glutam ⁇ ne, L-methionine, St.
- a beverage composition is prepared containing:
- Sodium Benzoate preservative The ingredients were obtained as follows: Glutamme (Twiniab Mega Glutamine); Milk Thistle Seed Extract (Gaia 1:1 (80% alcohol)); St. Johnswort Buds Extract (Gaia 1:1 (80% alcohol)); Vitamin C (Twiniab C-1000 cr/stalline); Vitamin B (Twiniab 3-1-group); Kudzu (Nat re's Herbs, 1 mg daidzm, 556 mg cap); Selenium (Solaray 100 meg); Zinc (Twiniab, Zn gluconate, honey and sweetened); 5-Hydroxy Tryptophan (extract Soiaray 100 mg & St.
- the beverage composition is clear, and has a light yellow color.
- the beverage has a light licence flavor similar to the flavor of dilute Galia ⁇ o liqueur.
- the beverage has the flavor of a soft drink, but maintains a bite and nose suggestive of an alcoholic drink.
- the mild flavor of the beverage can be masked, if desired, with other flavorants.
- the beverage has a satisfactory shelf-life.
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU42174/99A AU4217499A (en) | 1998-05-29 | 1999-05-28 | Composition having therapeutic and/or nutritionally active substituent |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8698498A | 1998-05-29 | 1998-05-29 | |
US09/086,984 | 1998-05-29 | ||
US19943298A | 1998-11-25 | 1998-11-25 | |
US09/199,432 | 1998-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999061038A1 true WO1999061038A1 (en) | 1999-12-02 |
Family
ID=26775376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/011886 WO1999061038A1 (en) | 1998-05-29 | 1999-05-28 | Composition having therapeutic and/or nutritionally active substituent |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4217499A (en) |
WO (1) | WO1999061038A1 (en) |
Cited By (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000078325A1 (en) * | 1999-06-20 | 2000-12-28 | Lycored Natural Products Industries Ltd. | Synergistic compositions containing lycopene and silymarin for treatment of liver disease |
NL1016783C2 (en) * | 2000-12-04 | 2002-06-05 | Business Quarters B V | Continuous production of a tryptophan-enriched milk beverage comprises adding a homogenized concentrated mixture of L-tryptophan and water to a milk beverage |
US6416806B1 (en) * | 2000-03-20 | 2002-07-09 | James H. Zhou | Herbal caffeine replacement composition and food products incorporating same |
WO2002092112A1 (en) * | 2001-05-11 | 2002-11-21 | Holford & Associates Limited | Oral supplement |
US6503543B1 (en) | 2000-05-26 | 2003-01-07 | Craig J. Hudson | Tryptophan source from plants and uses therefor |
WO2003011054A1 (en) * | 2001-08-02 | 2003-02-13 | Peter Marcinowski | Complex antioxidant preparation |
WO2003013495A1 (en) * | 2001-08-08 | 2003-02-20 | Smothers Don L | Formulation and method for reduction of stress in meat-producing animals |
EP1325747A2 (en) * | 2001-12-20 | 2003-07-09 | Health Pharma S.r.l | Dietary supplement for neuropaths |
WO2003101225A1 (en) * | 2002-05-31 | 2003-12-11 | Suomen Ravitsemusinstituutti Oy | A drink composition and a method for composing a drink |
FR2841782A1 (en) * | 2002-07-08 | 2004-01-09 | Clarins Lab | COSMETIC COMPOSITION CAPABLE OF FIGHTING AGING CUTANEOUS |
WO2004020403A2 (en) | 2002-08-27 | 2004-03-11 | Shell William E | A composition and method to augment and sustain neurotransmitter production |
WO2004030684A2 (en) * | 2002-10-03 | 2004-04-15 | Herbal Science, Llc | Kavalactone product |
WO2004089298A2 (en) * | 2003-04-03 | 2004-10-21 | Anlant Thompson Marshall | 5-htp composition |
WO2005009147A1 (en) * | 2003-07-31 | 2005-02-03 | Shannon Minerals Ltd. | Ready-to-drink formulation containing an active ingredient |
EP1504671A1 (en) * | 2003-07-30 | 2005-02-09 | Nestec S.A. | Controlled delivery of caffeine from high-caffeinated coffee beverages made from soluble powder |
JP2005041853A (en) * | 2003-07-25 | 2005-02-17 | T Langeland Bjorn | Composition stimulating specific metalloenzyme |
US6866874B2 (en) | 2000-05-26 | 2005-03-15 | Susan P. Hudson | Tryptophan source from plants and uses therefor |
US6936283B2 (en) * | 2003-07-25 | 2005-08-30 | Langeland Bjoern T. | Composition for stimulation of specific metallo-enzymes |
EP1581204A1 (en) * | 2002-12-24 | 2005-10-05 | New York University | Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (paba) |
EP1605764A2 (en) * | 2003-03-14 | 2005-12-21 | Pro-Health, Inc. | Composition and method for appetite and carvingsuppressission and mood enhancement |
US7029707B2 (en) | 2001-10-03 | 2006-04-18 | Herbalscience, Llc | Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
US7037524B2 (en) | 2001-10-03 | 2006-05-02 | Herbalscience, Llc | Oral delivery of a botanical |
US7048941B2 (en) * | 2001-03-30 | 2006-05-23 | New World Enterprizes, Inc. | Chocolate composition as delivery system for nutrients and medications |
EP1671550A1 (en) * | 2004-12-15 | 2006-06-21 | Herbalife International, Inc. | Energy drink compositions |
DE102005006241A1 (en) * | 2005-02-10 | 2006-08-17 | Patrick Faber | Use of tryptophan, food and drink |
US7105185B2 (en) | 2001-10-03 | 2006-09-12 | Herbalscience, Llc | Kavalactone profile |
WO2007019685A1 (en) * | 2005-08-12 | 2007-02-22 | Multi Formulations Ltd. | Supplemental dietary composition including caffeine, taurine and ginseng |
US7279184B2 (en) | 2003-10-24 | 2007-10-09 | Herbalscience, Llc | Methods and compositions comprising Ilex |
US7291352B2 (en) | 2001-10-03 | 2007-11-06 | Herbalscience Llc | Methods and compositions for oral delivery of Areca and mate' or theobromine |
US7294353B2 (en) | 2003-10-24 | 2007-11-13 | Herbalscience, Llc | Methods and compositions comprising ilex |
WO2008040756A1 (en) * | 2006-10-05 | 2008-04-10 | Dsm Ip Assets B.V. | Anandamide |
US7524815B2 (en) | 2001-04-03 | 2009-04-28 | Nestec S.A. | Osteoprotegerin in milk |
US7754700B2 (en) | 2006-04-24 | 2010-07-13 | Trager Seymour F | Composition and methods for alleviating symptoms of neurotoxicity |
US20100209557A1 (en) * | 2009-02-14 | 2010-08-19 | O'connor Daniel C | Recovery blends for liquid beverages |
CN101904351A (en) * | 2010-08-10 | 2010-12-08 | 河北三元食品有限公司 | Antialcoholic sour milk and preparation method thereof |
US7919125B2 (en) | 2001-06-20 | 2011-04-05 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
WO2011051742A1 (en) * | 2009-10-28 | 2011-05-05 | Modutech S.A. | Preparation comprising amino acids and plants and its activity in the alcohol detoxification |
JP2011189143A (en) * | 2001-12-28 | 2011-09-29 | Lahteenmaki Pertti | Nutrition dispenser and method for producing optimal dose of nutrition with the help of database mechanism |
EP2384648A1 (en) * | 2010-05-07 | 2011-11-09 | Deenox SAS | New compositions containing omega 3 and usage to treat hangover |
US8142800B1 (en) * | 2001-12-18 | 2012-03-27 | Tamea Rae Sisco | Oral high potency clinical anti-craving treatment and method of use |
US8142799B2 (en) * | 2001-12-18 | 2012-03-27 | Tamea Rae Sisco | High potency clinical anti-craving treatment and method of use |
EP2505080A1 (en) * | 2011-08-18 | 2012-10-03 | Sybille Pegel | Health promoting drink compound |
US8486457B2 (en) * | 2002-10-21 | 2013-07-16 | Metaproteomics, Llc. | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
RU2498607C2 (en) * | 2008-05-14 | 2013-11-20 | Унилевер Н.В. | Frozen confectionery products |
US8642581B1 (en) * | 2000-02-11 | 2014-02-04 | Brian D. Halevie-Goldman | Compositions and methods for the production of S-adenosylmethionine within the body |
CN103829342A (en) * | 2014-03-07 | 2014-06-04 | 焦作市恒伟饮品有限公司 | Functional health-protection beverage and preparation method thereof |
CN103843953A (en) * | 2014-03-01 | 2014-06-11 | 黄艳英 | Cannabis and fingered citron tea |
EP1996213A4 (en) * | 2006-03-22 | 2014-08-20 | Targeted Medical Pharma Inc | Method and compositions for potentiating pharmaceuticals with amino acid based medical foods |
US8846115B2 (en) | 2001-11-13 | 2014-09-30 | Metaproteomics, Inc. | Anti-inflammatory cyclooxygenase inhibitors |
CN104188004A (en) * | 2014-07-18 | 2014-12-10 | 马鞍山市安康菌业有限公司 | Needle mushroom-orange juice |
CN104223317A (en) * | 2014-09-29 | 2014-12-24 | 郭秀珍 | Preservative and preparation method thereof |
WO2015136382A1 (en) * | 2014-03-14 | 2015-09-17 | Ipc Intellectual Property Capital Deutschland Gmbh | Appetite-suppressing food product containing jerusalem artichoke flour |
WO2016046795A1 (en) * | 2014-09-26 | 2016-03-31 | Gianluca Mech | Protein dietary supplement |
US9446100B2 (en) | 2015-02-13 | 2016-09-20 | Eastern Vision Limited | Dietary supplements and formulations |
CN107509842A (en) * | 2017-08-29 | 2017-12-26 | 广西双泓商贸有限公司 | A kind of tea bag with healthcare function and preparation method thereof |
CN107624922A (en) * | 2017-10-09 | 2018-01-26 | 俞成莲 | A kind of anistree health preserving tea |
IT201600111508A1 (en) * | 2016-11-07 | 2018-05-07 | Masini Antonio | Nutritional Formulation based on Cocoa and specific plant extracts in combination with phosphatidylcholine to support brain functions in the elderly. |
WO2021069615A1 (en) | 2019-10-10 | 2021-04-15 | Zobrius Pharma As | Improved anti-hangover composition, its preparation and uses |
US11116809B2 (en) * | 2017-06-30 | 2021-09-14 | Promend Animal Health, Inc. | Biopolymer compositions for the treatment and prevention of liver disease |
WO2023183775A3 (en) * | 2022-03-22 | 2023-11-02 | Performance Labs PTE. LTD. | Botanical extraction |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4061797A (en) * | 1975-08-22 | 1977-12-06 | Hannan Jr Harry | Noncarbonated, caffeine-containing fruit and cola flavored beverage |
US4612205A (en) * | 1985-04-04 | 1986-09-16 | Procter & Gamble Company | Carbonated juice beverage with cola taste |
US4992282A (en) * | 1989-05-08 | 1991-02-12 | The Procter & Gamble Company | Stable nutritional vitamin and mineral supplemented beverage |
US5431940A (en) * | 1994-02-24 | 1995-07-11 | The Procter & Gamble Company | Preparation of noncarbonated beverage products with improved microbial stability |
US5455235A (en) * | 1992-04-10 | 1995-10-03 | Otsuka Pharmaceutical Co., Ltd. | Food composition for inhibiting the formation of an intestinal putrefactive product |
US5547671A (en) * | 1995-09-20 | 1996-08-20 | Duthinh; Phu | Anti-intoxication composition |
US5641532A (en) * | 1995-12-15 | 1997-06-24 | The Procter & Gamble Company | Beverages having stable flavor/cloud emulsions in the presence of polyphosphate-containing preservative systems by including gellan gum |
-
1999
- 1999-05-28 AU AU42174/99A patent/AU4217499A/en not_active Abandoned
- 1999-05-28 WO PCT/US1999/011886 patent/WO1999061038A1/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4061797A (en) * | 1975-08-22 | 1977-12-06 | Hannan Jr Harry | Noncarbonated, caffeine-containing fruit and cola flavored beverage |
US4612205A (en) * | 1985-04-04 | 1986-09-16 | Procter & Gamble Company | Carbonated juice beverage with cola taste |
US4992282A (en) * | 1989-05-08 | 1991-02-12 | The Procter & Gamble Company | Stable nutritional vitamin and mineral supplemented beverage |
US5455235A (en) * | 1992-04-10 | 1995-10-03 | Otsuka Pharmaceutical Co., Ltd. | Food composition for inhibiting the formation of an intestinal putrefactive product |
US5431940A (en) * | 1994-02-24 | 1995-07-11 | The Procter & Gamble Company | Preparation of noncarbonated beverage products with improved microbial stability |
US5547671A (en) * | 1995-09-20 | 1996-08-20 | Duthinh; Phu | Anti-intoxication composition |
US5641532A (en) * | 1995-12-15 | 1997-06-24 | The Procter & Gamble Company | Beverages having stable flavor/cloud emulsions in the presence of polyphosphate-containing preservative systems by including gellan gum |
Cited By (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000078325A1 (en) * | 1999-06-20 | 2000-12-28 | Lycored Natural Products Industries Ltd. | Synergistic compositions containing lycopene and silymarin for treatment of liver disease |
US8642581B1 (en) * | 2000-02-11 | 2014-02-04 | Brian D. Halevie-Goldman | Compositions and methods for the production of S-adenosylmethionine within the body |
US6416806B1 (en) * | 2000-03-20 | 2002-07-09 | James H. Zhou | Herbal caffeine replacement composition and food products incorporating same |
US6503543B1 (en) | 2000-05-26 | 2003-01-07 | Craig J. Hudson | Tryptophan source from plants and uses therefor |
US6866874B2 (en) | 2000-05-26 | 2005-03-15 | Susan P. Hudson | Tryptophan source from plants and uses therefor |
US6656473B2 (en) | 2000-05-26 | 2003-12-02 | Susan P. Hudson | Tryptophan source from plants and uses thereof |
NL1016783C2 (en) * | 2000-12-04 | 2002-06-05 | Business Quarters B V | Continuous production of a tryptophan-enriched milk beverage comprises adding a homogenized concentrated mixture of L-tryptophan and water to a milk beverage |
US7048941B2 (en) * | 2001-03-30 | 2006-05-23 | New World Enterprizes, Inc. | Chocolate composition as delivery system for nutrients and medications |
US7524815B2 (en) | 2001-04-03 | 2009-04-28 | Nestec S.A. | Osteoprotegerin in milk |
WO2002092112A1 (en) * | 2001-05-11 | 2002-11-21 | Holford & Associates Limited | Oral supplement |
US7919125B2 (en) | 2001-06-20 | 2011-04-05 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
WO2003011054A1 (en) * | 2001-08-02 | 2003-02-13 | Peter Marcinowski | Complex antioxidant preparation |
WO2003013495A1 (en) * | 2001-08-08 | 2003-02-20 | Smothers Don L | Formulation and method for reduction of stress in meat-producing animals |
US7105185B2 (en) | 2001-10-03 | 2006-09-12 | Herbalscience, Llc | Kavalactone profile |
US7291352B2 (en) | 2001-10-03 | 2007-11-06 | Herbalscience Llc | Methods and compositions for oral delivery of Areca and mate' or theobromine |
US7001620B2 (en) | 2001-10-03 | 2006-02-21 | Herbal Science, Llc | Kavalactone product |
US7037524B2 (en) | 2001-10-03 | 2006-05-02 | Herbalscience, Llc | Oral delivery of a botanical |
US7029707B2 (en) | 2001-10-03 | 2006-04-18 | Herbalscience, Llc | Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
US8846115B2 (en) | 2001-11-13 | 2014-09-30 | Metaproteomics, Inc. | Anti-inflammatory cyclooxygenase inhibitors |
US8142800B1 (en) * | 2001-12-18 | 2012-03-27 | Tamea Rae Sisco | Oral high potency clinical anti-craving treatment and method of use |
US8142799B2 (en) * | 2001-12-18 | 2012-03-27 | Tamea Rae Sisco | High potency clinical anti-craving treatment and method of use |
EP1325747A3 (en) * | 2001-12-20 | 2003-07-30 | Health Pharma S.r.l | Dietary supplement for neuropaths |
EP1325747A2 (en) * | 2001-12-20 | 2003-07-09 | Health Pharma S.r.l | Dietary supplement for neuropaths |
JP2011189143A (en) * | 2001-12-28 | 2011-09-29 | Lahteenmaki Pertti | Nutrition dispenser and method for producing optimal dose of nutrition with the help of database mechanism |
WO2003101225A1 (en) * | 2002-05-31 | 2003-12-11 | Suomen Ravitsemusinstituutti Oy | A drink composition and a method for composing a drink |
US7638148B2 (en) | 2002-05-31 | 2009-12-29 | Suomen Ravitsemusinstituutti Oy | Drink composition and a method for composing a drink |
JP2005527234A (en) * | 2002-05-31 | 2005-09-15 | スオメン・ラビットセムスインスティトゥーティ・オイ | Beverage composition and method for producing beverage |
FR2841782A1 (en) * | 2002-07-08 | 2004-01-09 | Clarins Lab | COSMETIC COMPOSITION CAPABLE OF FIGHTING AGING CUTANEOUS |
WO2004020403A3 (en) * | 2002-08-27 | 2004-06-24 | William E Shell | A composition and method to augment and sustain neurotransmitter production |
WO2004020403A2 (en) | 2002-08-27 | 2004-03-11 | Shell William E | A composition and method to augment and sustain neurotransmitter production |
WO2004030684A3 (en) * | 2002-10-03 | 2004-09-23 | Herbal Science Llc | Kavalactone product |
WO2004030684A2 (en) * | 2002-10-03 | 2004-04-15 | Herbal Science, Llc | Kavalactone product |
US8486457B2 (en) * | 2002-10-21 | 2013-07-16 | Metaproteomics, Llc. | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7691905B2 (en) | 2002-12-24 | 2010-04-06 | New York University | Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA) |
EP1581204A1 (en) * | 2002-12-24 | 2005-10-05 | New York University | Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (paba) |
EP1581204A4 (en) * | 2002-12-24 | 2009-01-28 | Univ New York | Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (paba) |
EP1605764A2 (en) * | 2003-03-14 | 2005-12-21 | Pro-Health, Inc. | Composition and method for appetite and carvingsuppressission and mood enhancement |
EP1605764A4 (en) * | 2003-03-14 | 2008-07-23 | Eurark Llc | Composition and method for appetite and carvingsuppressission and mood enhancement |
WO2004089298A2 (en) * | 2003-04-03 | 2004-10-21 | Anlant Thompson Marshall | 5-htp composition |
WO2004089298A3 (en) * | 2003-04-03 | 2006-03-30 | Anlant Thompson Marshall | 5-htp composition |
JP2005041853A (en) * | 2003-07-25 | 2005-02-17 | T Langeland Bjorn | Composition stimulating specific metalloenzyme |
US6936283B2 (en) * | 2003-07-25 | 2005-08-30 | Langeland Bjoern T. | Composition for stimulation of specific metallo-enzymes |
EP1504671A1 (en) * | 2003-07-30 | 2005-02-09 | Nestec S.A. | Controlled delivery of caffeine from high-caffeinated coffee beverages made from soluble powder |
WO2005013711A1 (en) * | 2003-07-30 | 2005-02-17 | Nestec S.A. | Controlled delivery of caffeine from high-caffeinated coffee beverages made from soluble powder |
WO2005009147A1 (en) * | 2003-07-31 | 2005-02-03 | Shannon Minerals Ltd. | Ready-to-drink formulation containing an active ingredient |
US7279184B2 (en) | 2003-10-24 | 2007-10-09 | Herbalscience, Llc | Methods and compositions comprising Ilex |
US7294353B2 (en) | 2003-10-24 | 2007-11-13 | Herbalscience, Llc | Methods and compositions comprising ilex |
EP1671550A1 (en) * | 2004-12-15 | 2006-06-21 | Herbalife International, Inc. | Energy drink compositions |
WO2006065255A1 (en) * | 2004-12-15 | 2006-06-22 | Herbalife International, Inc. | Energy drink compositions |
DE102005006241A1 (en) * | 2005-02-10 | 2006-08-17 | Patrick Faber | Use of tryptophan, food and drink |
WO2007019685A1 (en) * | 2005-08-12 | 2007-02-22 | Multi Formulations Ltd. | Supplemental dietary composition including caffeine, taurine and ginseng |
EP1996213A4 (en) * | 2006-03-22 | 2014-08-20 | Targeted Medical Pharma Inc | Method and compositions for potentiating pharmaceuticals with amino acid based medical foods |
US7754700B2 (en) | 2006-04-24 | 2010-07-13 | Trager Seymour F | Composition and methods for alleviating symptoms of neurotoxicity |
WO2008040756A1 (en) * | 2006-10-05 | 2008-04-10 | Dsm Ip Assets B.V. | Anandamide |
RU2498607C2 (en) * | 2008-05-14 | 2013-11-20 | Унилевер Н.В. | Frozen confectionery products |
US20100209557A1 (en) * | 2009-02-14 | 2010-08-19 | O'connor Daniel C | Recovery blends for liquid beverages |
WO2011051900A1 (en) | 2009-10-28 | 2011-05-05 | Modutech S.A. | Preparation comprising amino acids and plants and its activity in the alcohol detoxification |
WO2011051742A1 (en) * | 2009-10-28 | 2011-05-05 | Modutech S.A. | Preparation comprising amino acids and plants and its activity in the alcohol detoxification |
US9192638B2 (en) | 2009-10-28 | 2015-11-24 | Modutech S.A. | Preparation comprising amino acids and plants and its activity in the alcohol detoxification |
US9526753B2 (en) | 2009-10-28 | 2016-12-27 | Modutech S.A. | Preparation comprising amino acids and plants and its activity in the alcohol detoxification |
EP2384648A1 (en) * | 2010-05-07 | 2011-11-09 | Deenox SAS | New compositions containing omega 3 and usage to treat hangover |
CN101904351A (en) * | 2010-08-10 | 2010-12-08 | 河北三元食品有限公司 | Antialcoholic sour milk and preparation method thereof |
EP2505080A1 (en) * | 2011-08-18 | 2012-10-03 | Sybille Pegel | Health promoting drink compound |
CN103843953A (en) * | 2014-03-01 | 2014-06-11 | 黄艳英 | Cannabis and fingered citron tea |
CN103829342A (en) * | 2014-03-07 | 2014-06-04 | 焦作市恒伟饮品有限公司 | Functional health-protection beverage and preparation method thereof |
WO2015136382A1 (en) * | 2014-03-14 | 2015-09-17 | Ipc Intellectual Property Capital Deutschland Gmbh | Appetite-suppressing food product containing jerusalem artichoke flour |
CN104188004A (en) * | 2014-07-18 | 2014-12-10 | 马鞍山市安康菌业有限公司 | Needle mushroom-orange juice |
WO2016046795A1 (en) * | 2014-09-26 | 2016-03-31 | Gianluca Mech | Protein dietary supplement |
CN104223317A (en) * | 2014-09-29 | 2014-12-24 | 郭秀珍 | Preservative and preparation method thereof |
US9446100B2 (en) | 2015-02-13 | 2016-09-20 | Eastern Vision Limited | Dietary supplements and formulations |
US10105419B2 (en) | 2015-02-13 | 2018-10-23 | Eastern Vision Limited | Dietary supplements and formulations |
IT201600111508A1 (en) * | 2016-11-07 | 2018-05-07 | Masini Antonio | Nutritional Formulation based on Cocoa and specific plant extracts in combination with phosphatidylcholine to support brain functions in the elderly. |
US11116809B2 (en) * | 2017-06-30 | 2021-09-14 | Promend Animal Health, Inc. | Biopolymer compositions for the treatment and prevention of liver disease |
CN107509842A (en) * | 2017-08-29 | 2017-12-26 | 广西双泓商贸有限公司 | A kind of tea bag with healthcare function and preparation method thereof |
CN107624922A (en) * | 2017-10-09 | 2018-01-26 | 俞成莲 | A kind of anistree health preserving tea |
WO2021069615A1 (en) | 2019-10-10 | 2021-04-15 | Zobrius Pharma As | Improved anti-hangover composition, its preparation and uses |
WO2023183775A3 (en) * | 2022-03-22 | 2023-11-02 | Performance Labs PTE. LTD. | Botanical extraction |
Also Published As
Publication number | Publication date |
---|---|
AU4217499A (en) | 1999-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999061038A1 (en) | Composition having therapeutic and/or nutritionally active substituent | |
US20010008641A1 (en) | Nutritionally active composition for bodybuilding | |
US20210283137A1 (en) | Method of making composition including encapsulated caffeine | |
US11717507B2 (en) | Compositions and methods for preventing and recovery from detrimental effects of alcohol consumption | |
US20130015204A1 (en) | Single-use containers and uses thereof | |
US20060134300A1 (en) | Nutritional supplement for caffeine-containing beverages | |
EP3160590B1 (en) | Nutrients solutions for enhancement of cognitive function | |
US8642095B2 (en) | Dietary composition and method of using the same | |
US20160213624A1 (en) | Composition, Commericial Product and Method for Treating Cannabis Toxicity | |
US20170119836A1 (en) | Method of making a liquid composition | |
US8507015B2 (en) | Composition for countering the effects of alcohol consumption | |
CN109715168A (en) | For treating the composition being still drank after a night | |
US20030148016A1 (en) | Energy fitness water | |
WO2000003679A2 (en) | Nutritionally active composition for hardening fingernails | |
US20060094734A1 (en) | Composition and method for inducing alertness | |
US20120294952A1 (en) | Antitussive compositions and methods | |
US20110027192A1 (en) | Slim-fit fat burning water | |
WO2014133562A1 (en) | Dry powdered comestibles and packaging therefor | |
AU2015234318A1 (en) | Single-use containers and uses thereof | |
AU2020465484A1 (en) | Caffeinated botanical infusion beverage and method of making same | |
US20140129484A1 (en) | Method of marketing protein hydrolysate for high energy sensation | |
Safe | REAL NRG™ | |
Evatt et al. | Caffeine, Addiction, and Food Consumption | |
US20130189391A1 (en) | Dry Powdered Comestibles | |
DE202011108758U1 (en) | structure drink |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |